APPARATUS AND METHOD FOR APPLYING A SOLUTION ON SKIN

FIELD OF THE INVENTION

The present invention generally relates to the field of solution application. In particular, the present invention is directed to apparatus and method for applying a solution on skin.

BACKGROUND

Traditional methods of applying solutions on the skin often result in uneven distribution, leading to inconsistent outcomes and potential product wastage. Many existing application devices lack precision, making it challenging to target specific areas while avoiding undesired exposure to sensitive regions such as the eyes or mouth.

SUMMARY OF THE DISCLOSURE

In an aspect, an apparatus for applying a solution on skin includes a solution applying module, wherein the solution applying module is configured to apply a solution on skin, a reservoir, wherein the reservoir is configured to store the solution, and a solution flow generating module, wherein the solution flow generating module is configured to generate a flow of the solution between the reservoir and the solution applying module.

In another aspect, a method for applying a solution on skin includes storing, using a reservoir, a solution, generating, using a solution flow generating module, a flow of the solution between the reservoir and a solution applying module, and applying, using the solution applying module, the solution on skin.

These and other aspects and features of non-limiting embodiments of the present invention will become apparent to those skilled in the art upon review of the following description of specific non-limiting embodiments of the invention in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

For the purpose of illustrating the invention, the drawings show aspects of one or more embodiments of the invention. However, it should be understood that the present invention is not limited to the precise arrangements and instrumentalities shown in the drawings, wherein:

FIG. 1 illustrates a block diagram of an exemplary apparatus of applying a solution on skin;

FIG. 2 illustrates an exemplary embodiment of an apparatus for applying solution on skin;

FIGS. 3A-3I illustrate exemplary illustrations of an apparatus for applying solution on skin;

FIG. 4 illustrates a flow diagram of an exemplary method of applying solution on skin; and

FIG. 5 illustrates a block diagram of a computing system that can be used to implement any one or more of the methodologies disclosed herein and any one or more portions thereof.

The drawings are not necessarily to scale and may be illustrated by phantom lines, diagrammatic representations and fragmentary views. In certain instances, details that are not necessary for an understanding of the embodiments or that render other details difficult to perceive may have been omitted.

DETAILED DESCRIPTION

At a high level, aspects of the present disclosure are directed to apparatus and method for applying solution on skin. The apparatus including a solution applying module, wherein the solution applying module is configured to apply a solution on skin, a reservoir, wherein the reservoir is configured to store the solution and a solution flow generating module, wherein the solution flow generating module is configured to generate a flow of the solution between the reservoir and the solution applying module. Exemplary embodiments illustrating aspects of the present disclosure are described below in the context of several specific examples.

Referring now to FIG. 1, a block diagram of an exemplary apparatus 100 of applying a solution on skin. Apparatus 100 includes a solution applying module 104, wherein the solution applying module 104 is configured to apply a solution on skin. For the purposes of this disclosure, a “solution applying module” is a device, tool or system designed to release a solution. Solution applying module 104 may include plastics, stainless steel, glass, rubber, silicone, ceramics, or the like. In some embodiments, solution applying module 104 may be stationary; for instance, a user may manually control solution applying module 104 to apply solution 108 on skin. In some embodiments, solution applying module 104 may be movable; for instance, solution applying module 104 may be controlled using at least an actuator to apply solution 108 on skin. In a non-limiting example, solution applying module 104 may apply solution on face, facial follicles, beard, body follicles, arms, legs, scalp, hair, or the like. Actuator disclosed herein is further described below. As used in this disclosure, a “solution” is a composition comprising one or more substances dissolved, dispersed, or suspended within a solvent. Without limitation, the solution 108 may include all possible dosages and formulations that may be dispensed by a solution applicator. Continuing, the solution applying module 104 may be compatible with a wide range of dosages and formulations, allowing the solution applying module 104 to apply any dosage, and the solution 108 may include any substance suitable for application. The solution may also be referred to as the “product” within this disclosure. Without limitation, the solution 108 may include active ingredients, carriers, stabilizers, or excipients, and may be formulated to perform a specific function, such as promoting facial hair growth, moisturizing the skin, or delivering therapeutic agents. Continuing, the solution 108 may be stored in the reservoir 112 and dispensed through an applicator for application to the skin or other surfaces.

With continued reference to FIG. 1, in a non-limiting example, the solution may be consistent with one or more aspects of the composition for stimulating facial hair growth described in attorney docket number 1197-001USU1, U.S. patent application Ser. No. 17/855,206, filed on Jun. 30, 2022, titled “COMPOSITION FOR STIMULATING FACIAL HAIR GROWTH AND METHODS OF MANUFACTURING A COMPOSITION FOR STIMULATING FACIAL HAIR GROWTH,” which is incorporated by reference herein in its entirety.

With continued reference to FIG. 1, in an embodiment, the solution applying module 104 may incorporate precision application features designed to deliver a drug product to a specific area with accuracy as further described herein. Continuing, the precision application features may help minimize the risk of inadvertent exposure to sensitive areas, such as the eyes, nose, and mouth, promoting safer and more effective usage. Without limitation, by enabling targeted application, the solution applying module 104 may improve the drug's efficacy while reducing the potential for side effects caused by unintended contact with surrounding regions as detailed below. In another embodiment, the solution applying module 104 may offer increased convenience through a hands-free delivery system. Continuing, the hands-free delivery system may eliminate the need for direct manual application, thereby reducing cleanup and enhancing ease of use. Without limitation, the hands-free nature of the solution applying module 104 may appeal to users seeking a more efficient and hygienic method for drug application, improving the overall user experience. In another non-limiting example, the solution applying module 104 may include an applicator head that facilitates the distribution of the drug product into the skin, particularly between hair follicles, as described herein. Continuing, this functionality may ensure optimal absorption of the drug for improved treatment outcomes. Additionally, the solution applying module 104 may feature metered dosing capabilities, which may dispense a precise and targeted dose during each application as discussed herein. Without limitation, such precision may minimize waste and ensure consistency, providing a reliable and effective means for drug administration.

With continued reference to FIG. 1, in some embodiments, solution applying module 104 may be reusable, disposable, replaceable, or the like. In some embodiments, solution applying module 104 may include a nozzle, mesh, and/or other form of aerosol forming component. In some embodiments, solution applying module 104 may be removable, such as through a screw-like structure, cap, or other securing mechanism. In some embodiments, solution applying module 104 may be configured to output a spray, wherein the spray may be parallel to the orientation of solution applying module 104. In another embodiment, solution applying module 104 may be oriented upward. In another embodiment, solution applying module 104 may be oriented to the side.

With continued reference to FIG. 1, in some embodiments, solution applying module 104 may include a rollerball applicator. As used in this disclosure a “rollerball applicator” is a device and/or component that applies one or more substances to facial follicle as a function of a rollerball. For example, and without limitation, rollerball applicator may include a device and/or component that stores solution 108 in a tube (reservoir 112) that has a first end and a second end, wherein the first end is blocked as a function of a cap and/or wall, and wherein the second end is blocked by a ball and/or sphere. In an embodiment, and without limitation, rollerball applicator may be configured to expel a liquid phase solution 108 from the tube as a function of the ball and/or sphere rotating and/or rolling. For example, and without limitation, the ball may rotate, wherein the liquid phase composition may be expelled as a function of the ball drawing the liquid phase composition from the tube. Additionally or alternatively, solution 108 may include a foam. As used in this disclosure a “foam” is an object and/or substance that is formed as a function of trapping pockets of gas and/or liquid in a solid. For example, and without limitation, foam may include a closed-cell and/or open-cell foam as a function of the location of the gas pockets. As a further non-limiting example, foam may include a liquid foam that releases a gas pocket as a function of a manipulation and/or movement of the foam. In an embodiment, foam may store and/or stabilize solution 108 such that solution 108 may be easily applied to an individual's extremities, face, skin, and the like thereof. Additionally or alternatively, solution applying module 104 may include one or more gels, ointments, creams, powders, lotions, pastes, balms, and the like thereof. Alternatively or additionally, solution applying module 104 may include a spray applicator. A spray applicator may include a tube (reservoir 112) for storing solution 108. Tube may include any tube as discussed herein. A spray applicator may include a spray nozzle that facilitated a dispersion of solution 108 into a spray. In an embodiment, the solution applying module 104 may include a spray nozzle capable of dispensing the solution 108 as an aerosol. A spray applicator may be configured to expel a liquid phase composition from the tube directly onto an individual/a facial follicle.

With continued reference to FIG. 1, in another embodiment, solution applying module 104 may comprise a pad-based applicator. As used in this disclosure, a “pad-based applicator” is a device and/or component that applies one or more substances to facial follicles using a pad. For example, and without limitation, pad-based applicator may include an outer casing (reservoir 112) that may contain solution 108 along with a plurality of pads. Outer casing may have a first end and a second end, wherein the first end is blocked as a function of a wall, and wherein the second end is blocked by a cap (housing 116) that may be temporarily removed to access the pads within. In some embodiments, the cap may be a door, lid, hinged opening, sliding door, and the like. Outer casing may be in contact with a surface of a pad/pads. Housing 116 may prevent the pad/pads and/or solution 108 from being in contact with external environments. In another embodiment, pad-based applicator may include a device and/or component that stores solution 108 and one or more pads in a sealed package. A sealed package (housing 116) may include a top wall and a bottom wall, wherein the pad/pads and solution 108 may be placed within. Top wall and a bottom wall may be adhered or otherwise joined together to form a compartment before the pad/pads and solution 108 may be placed inside. Package may be composed of a thin metal such as aluminum and/or a thin plastic such that the package is still flexible.

Continuing to reference FIG. 1, pad-based applicator may include a pad. The pad may be constructed from a flexible, pliant, soft material, such as cotton, polypropylene, nylon, viscose, flax, or the like. A pad may include hydrophilic materials and/or hydrophobic materials such as polyethylene terephthalate or polypropylene. Pad may include several layers of materials. In an embodiment, pad may include 3 layers of material. In another embodiment, pad may include 1 layer of material. A pad may be pre-soaked in solution 108 such that application of the solution 108 consists of applying the pad to an individual's extremities, face, skin, and the like thereof. Liquid-phased composition may be expelled from the pad, by way of application. The individual may apply a force to the pad such that the pad expels solution 108 to a desired location. In an embodiment, pad-based applicator may store and/or stabilize solution 108 such that solution 108 may be easily applied to an individual's extremities, face, skin, and the like thereof.

With continued reference to FIG. 1, in an embodiment, the pad-based applicator of solution applying module 104 may include an integrated dispensing mechanism that facilitates precise application of solution 108 to a targeted area. The pad-based applicator may consist of an outer casing (reservoir 112) designed to hold solution 108 securely while maintaining hygiene and preventing contamination. The casing may include a dispensing system, such as a pump or squeezable reservoir, to release a controlled amount of solution onto the pad when activated by the user.

With continued reference to FIG. 1, in an embodiment, the pad-based applicator of solution applying module 104 may be constructed from layered materials designed for optimal performance during application. For instance, without limitation, the pad-based applicator may include a hydrophilic top layer to absorb and retain the solution, a middle layer for structural support and fluid distribution, and a hydrophobic bottom layer to prevent solution leakage. Continuing, without limitation, these layers may be bonded together to create a durable yet flexible applicator. In some embodiments, without limitation the pad-based applicator may include micro-perforations or textured surfaces to enhance solution delivery and improve contact with the skin. In another non-limiting example, the pad-based applicator may be attached to or integrated with a removable or hinged cap (housing 116) that seals the reservoir when not in use. Without limitation, the cap may feature an alignment mechanism, such as grooves or notches, to ensure that the pad remains securely positioned against the dispensing outlet of the reservoir. Continuing, upon opening, the cap may expose the pre-soaked pad, allowing the user to apply the pad directly to facial follicles, extremities, or other areas of the body by exerting gentle pressure. In another embodiment, the pad-based applicator may be configured for disposable use, wherein each pad is pre-packaged in a sealed compartment along with solution 108. Without limitation, the sealed package may include a tear-away or peel-off cover, providing a sterile environment for the pad until it is ready for application. Without limitation, the packaging may be composed of flexible materials, such as aluminum or plastic, to ensure portability and ease of use. Continuing, this design may allow for single-use application, minimizing contamination and ensuring consistent dosage. The pad-based applicator may offer versatility in its use by accommodating pads of various sizes and shapes, depending on the intended application. Additionally and or alternatively, the applicator may be refillable, allowing the user to replace used pads and replenish solution 108 as needed. Without limitation, these features may enhance the functionality and usability of the pad-based applicator, making it suitable for a wide range of personal care applications. Exemplary configurations of solution applying module 104 are shown in FIGS. 2-3D.

Still referring to FIG. 1, solution applying module 104 may be configured to enhance stability of vasodilator and/or additive. In some embodiments, solution applying module 104 may increase a delivery of solution 108 to facial follicles. A stability of solution applying module 104 may improve a patient adherence to using solution 108. As used in this disclosure a “stability” is a measurable value denoting the magnitude of reactivity of a compound. For example, and without limitation, stability may denote that vasodilator has a high stability as a function of a low Gibbs Free Energy. As a further non-limiting example, stability may denote that additive has a low stability as a function of a high Gibbs Free Energy.

In an embodiment, and still referring to FIG. 1, solution applying module 104 may dissolve and/or liquefy vasodilator and/or additive as a function of a solubility property, wherein solubility properties are described below. In another embodiment, and without limitation, solution applying module 104 may suspend and/or mix vasodilator and/or additive as a function of an emulsion. In an embodiment, and without limitation, solution applying module 104 may suspend and/or mix vasodilator and/or additive as a function of a liposome, nanoliposome, nano-lipid sphere, transfersome, noisome, ethosome, nanovesicle, and the like thereof. In an embodiment, and without limitation, solution applying module 104 or solution 108 may comprise an ionic liquid. As used in this disclosure an “ionic liquid” is a salt substance and/or analyte that is in a liquid state. In an embodiment, and without limitation, ionic liquid may comprise one or more substances such as, but not limited to, liquid electrolytes, ionic melts, ionic fluids, fused salts, liquid salts, ionic glasses, and the like thereof. In another embodiment, and without limitation, ionic liquid may comprise one or more liquids that comprise an organic cation and/or a substance and/or analyte that maintains a low lattice energy. In an embodiment, and without limitation, ionic liquid may be configured to reduce a propensity of a polymorphic structure of vasodilator. As used in this disclosure a “polymorphic structure” is a solid material comprising a plurality of crystal structures. For example, and without limitation polymorphic structure may include a solid substance and/or analyte that comprises a plurality of crystal structures such as α,β,γ,δ, and the like thereof phases. In an embodiment, and without limitation, ionic liquid may reduce the propensity of a polymorphic structure of vasodilator as a function a solubility property. As used in this disclosure a “solubility property” is a chemical property of a substance and/or analyte to dissolve a solute and/or analyte. For example, and without limitation, solubility property of ionic liquids may be diverse as a function of a common-ion effect, ionic strength element, solubility equilibrium, temperature, and the like thereof. Additionally, and in an embodiment, solution applying module 104 may apply the vasodilator uniformly to the skin of a human. Uniform application may allow for uniform hair growth. Application of the composition is discussed in further detail below.

Still referring to FIG. 1, ionic liquid may include a room-temperature ionic liquid. As used in this disclosure a “room-temperature ionic liquid” is an ionic liquid that exists in a liquid state at room temperature. For example, and without limitation, room-temperature ionic liquid may comprise one or more salts derived from 1-methylimidazole. For example, and without limitation, salts derived from 1-methylimidazole may include 1-alkyl-3-methylimidazolium, 1-ethyl-3-methyl, 1-butyl-3-methyl, 1-octyl-3-methyl, 1-decyl-3-methyl, 1-dodecyl-3-methyl-dodecyl, and the like thereof. As a further non-limiting example, salts derived from 1-methylimidazole may include 1-butyl-2,3-dimethylimidazolium, 1,3-di(N,N-dimethylaminoethyl)-2-methylimidazolium, 1-butyl-2,3-dimethylimidazolium, and the like thereof. In an embodiment, and without limitation, room-temperature ionic liquid may comprise one or more cations derived from pyridine such as, but not limited to 4-methyl-N-butyl-pyridinium, N-octylpyridinium, and the like thereof. In another embodiment, and without limitation, room-temperature ionic liquid may comprise one or more cations such as tetraethylammonium, tetrabutyl ammonium, phosphonium, and the like thereof cations. Additionally or alternatively, room-temperature ionic liquid may comprise one or more anions such as but not limited to tetrafluoroborate, hexafluorophosphate, bis-trifluoromethanesulfonimide, trifluoromethanesulfonate, dicyanamide, hydrogen sulphate, ethyl sulphate, and the like thereof. In an embodiment, and without limitation, ionic liquid may be comprised of a low-temperature ionic liquid, protic ionic liquid, poly-ionic liquid, magnetic ionic liquid, and the like thereof. In another embodiment, ionic liquids may increase transcellular transport as a function of a choline-based bioinspired ionic liquid, such as but not limited to, choline phenylalaninate. In another embodiment, ionic liquids may increase permeation rate as a function of an imidazole based ionic liquid such as, but not limited to, ionic liquids derived from 1-methylimidazole as described above.

With continued reference to FIG. 1, for the purposes of this disclosure, a “solution” is a mixture composed of two or more substances. In some embodiments, solution 108 may include solid, semi-solid, liquid, gas, or the like. Without limitation, solution 108 may include, without limitation, one or more substances uniformly dispersed within a continuous phase, regardless of its physical state. In an embodiment, solution 108 may include a range of formulations, including but not limited to liquid solutions, semi-solid formulations such as gels and lotions, and other viscous or non-viscous compositions. In a non-limiting example, solution 108 may include lotion, cream, ointment, wax, foam, gel, spray, or the like. In another non-limiting example, solution 108 may include a mixture of liquid and solid or any mixture thereof. For example, and without limitation, solution 108 may include cream that includes granules or particles (solid) including additives. For example, and without limitation, solution 108 may include a mixture of substances that changes its state from solid to liquid, liquid to gas, solid to gas, or vice versa in response to temperature variations. As used in this disclosure, “liquid” is any fluid that flows freely and conforms to the shape of its container but retains a constant volume independent of pressure. As a non-limiting example, liquid may include water, oil, alcohol, and the like. As a non-limiting example, the alcohol may be ethanol. As used in this disclosure, a “solid” is any substance that includes a structural rigidity. As a non-limiting example, the solid may include a dissolvent. As used in this disclosure, a “dissolvent” is a substance that is initially a solid but then gets dissolved into a fluid. In some embodiments, the dissolvent may get dissolved into liquid. As used in this disclosure, a “gas” is a substance in a state in which it will expand freely to fill the whole of a container, having no fixed shape and no fixed volume. Exemplary solution 108 may include vasodilator, additive, solution applying module 104, water, air, ethanol, or the like. In some embodiments, solution 108 may stimulate facial hair growth. As used in this disclosure “facial hair” is hair and/or follicles that grows on an individual. In an embodiment, and without limitation, facial hair may include one or more hairs and/or follicles that grow along an individual's chin, cheeks, upper lip region, neck, and the like thereof.

With continued reference to FIG. 1, as used in this disclosure a “vasodilator” is a product that promotes the dilation of at least a blood vessel of an individual. In an embodiment, and without limitation, vasodilator may include one or more products that interact with an individual such that a relaxation of smooth muscle surrounding blood vessels occurs. In another embodiment, and without limitation, vasodilator may include one or more products that lower intracellular calcium concentrations of an individual. In an embodiment, and without limitation, vasodilator may include a product that changes the resting membrane potential of a cell to lower the concentration of the intracellular calcium as a function of modulating voltage-sensitive calcium channels in the plasma membrane of the cell. In an embodiment, and without limitation, vasodilator may include one or more products that dephosphorylate myosin. In an embodiment and without limitation, vasodilator may include one or more products that stimulate adrenergic receptors to elevate levels of cAMP and/or protein kinase A. In another embodiment, and without limitation, vasodilator may include one or more products that stimulate protein kinase G. In another embodiment, and without limitation, vasodilator may include one or more products that inhibit PDE5. In another embodiment, and without limitation, vasodilator may include one or more products that open potassium channels located along the cell membrane. Additionally or alternatively, vasodilator may be configured to be 0-5% weight/volume of solution 108. For example, and without limitation, vasodilator may be configured to compose 3.2% weight/volume of solution 108. As a further non-limiting example, vasodilator may be configured to be 1.1% weight/volume of solution 108. In an embodiment, vasodilator may be configured to enhance a permeation rate.

With continued reference to FIG. 1, in an embodiment, and without limitation, vasodilator may be configured to enhance a permeation rate of a nutrient. As used in this disclosure a “nutrient” is a substance that produces a source of energy to a cell and/or organism such that the cell and/or organism may grow, and/or reproduce. As a non-limiting example, nutrient may include, without limitation, a carbohydrate, such as glucose, sucrose, ribose, amylose, amylopectin, maltose, galactose, fructose, lactose, and the like thereof. Nutrient may include, without limitation, a protein, such as a standard amino acid, wherein a standard amino acid includes, but is not limited to, alanine, arginine, aspartic acid, asparagine, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, valine, and the like thereof. Nutrient may include without limitation a fat, such as a saturated fatty acid, monounsaturated fatty acid, polyunsaturated fatty acid, essential fatty acid, and the like thereof. Nutrient may include, without limitation, a vitamin, wherein a vitamin includes vitamins A, B1, B2, B3, B5, B6, B7, B9, B12, C, D, E, K, and the like thereof. Nutrient may include, without limitation, a mineral, such as potassium, chlorine, sodium, calcium, phosphorous, magnesium, iron, zinc, manganese, copper, iodine, chromium, molybdenum, selenium, cobalt, and the like thereof. Nutrient may include, without limitation, a hormone, wherein a hormone includes hormones such as, but not limited to, testosterone, dihydrotestosterone, dehydroepiandrosterone, androstenedione, progesterone, estriol, estradiol, estrone and the like thereof.

Still referring to FIG. 1, solution 108 may include a medication. As used in this disclosure a “medication” is a substance used for a medical treatment of a physiological process. For example, and without limitation, medication may include one or more drugs and/or pharmaceuticals. For example, and without limitation, medication may include one or more angiotensin-converting enzyme inhibitors such as, but not limited to, benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolapril. As a further non-limiting example, medication may include one or more angiotensin receptor blockers such as, but not limited to azilsartan, candesartan, eprosartan, irbesartan, telmisartan, valsartan, losartan, olmesartan, and the like thereof. As a further non-limiting example, medication may include one or more calcium channel blockers such as, but not limited to, amlodipine, clevidipine, diltiazem, felodipine, isradipine, nicardipine, nimodipine, nisoldipine, verapamil, and the like thereof. As a further non-limiting example, medication may include one or more nitrates such as, but not limited to nitroglycerin, isosorbide mononitrate, isosirbide dinitrate, hydralazine, fenoldopam, nitoprusside, and the like thereof.

Still referring to FIG. 1, medication may be configured to stimulate cell proliferation of a plurality of facial follicles of an individual. As used in this disclosure “cell proliferation” is a process that increases a number of cells of an individual. For example, and without limitation, cell proliferation may include one or more cell growths and/or cell divisions to produce two daughter cells, wherein a “daughter cell,” as used herein, is a cell that originates as a function of a parent cell growing and dividing to two smaller cells. As a further non-limiting example, cell proliferation may include a process that leads to an exponential increase in a cell magnitude and/or cell number. As a further non-limiting example, cell proliferation may include one or more processes that are regulated as a function of a signal transduction and/or cell-cell communicative pathway. As used in this disclosure a “facial follicle” is an organ located in the skin of the face of an individual. In an embodiment, and without limitation facial follicle may reside in the dermal layer of the skin of an individual. In another embodiment, facial follicle may be composed of up to 20 distinct cell types. For example, and without limitation, facial follicle may be composed of papilla cells, hair matrix cells, root sheath cells, cuboid cells, internal cuticle cells, stem cells, infundibulum cells, arrector pili cells, sebaceous cells, apocrine sweat cells, and the like thereof. In another embodiment, and without limitation, facial follicle may regulate the growth of hair as a function of a complex interaction between hormones, neuropeptides, and immune cells. In another embodiment, facial follicle may include one or more follicular phases, wherein a follicular phase is a sequential stage denoting the cycle of growth of a hair and/or hair follicle. For example, and without limitation, medication may be configured to promote a telogenic phase to shed facial follicle as described below, in reference to FIG. 2. As a further non-limiting example medication may be configured to promote an anagenic phase to proliferate facial follicle as described below. The present invention may be used to enhance stimulation of facial hair growth of the trans male population.

In an embodiment, and still referring to FIG. 1, medication may comprise minoxidil. As used in this disclosure “minoxidil” is a nitrate medication comprising a 2,4-diamino-6-piperidinopyrimidine 3-oxide structure. In an embodiment and without limitation, minoxidil may be a medication capable of reducing blood pressure of an individual. As a further non-limiting example, minoxidil may be a medication capable of reducing and/or reversing hair loss of an individual. As a further non-limiting example, minoxidil may be a medication capable of stimulating hair growth of an individual. Additionally or alternatively, medication may be configured to hyperpolarize a cell membrane of a cell. As used in this disclosure “hyperpolarizing” is a process of altering and/or modifying a cell membrane potential to increase the amount of negativity of the cell membrane. For example, and without limitation, hyperpolarizing a cell membrane may include increasing the amount of negativity of a cell membrane from −50 mV to −80 mV. As a further non-limiting example, hyperpolarizing a cell membrane may include increasing the amount of negativity of a cell membrane from −70 mV to −90 mV.

In an embodiment, and still referring to FIG. 1, medication may comprise finasteride. As used in this disclosure, “finasteride” is a 5-alpha reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT). In an embodiment, and without limitation, finasteride may be a medication capable of promoting hair growth and preventing further hair loss of an individual. Finasteride may be present between 0.01-3% of the weight to volume ratio of the solution 108. In an embodiment, finasteride may be 0.2% of the weight to volume ratio of the solution 108. In another embodiment, finasteride may be 2% of the weight to volume ratio of the solution 108. In another embodiment, finasteride may be 0.01% of the weight to volume ratio of the solution 108.

With continued reference to FIG. 1, in some embodiments, solution 108 may include a scent compound. As a non-limiting example, scent compound may include essential oil, or the like. As used in this disclosure, “scent” is a distinctive smell. As a non-limiting example, the scent may include floral scent, woody scent, fruity scent, fresh scent, and the like. As a non-limiting example, floral scent may include eucalyptus scent, jasmine scent, lavender smell, rosemary smell, and the like. As a non-limiting example, woody scent may include sandalwood scent, pine scent, cedarwood scent, and the like. As a non-limiting example, fruity scent may include lemon scent, mango scent, mango scent, passion fruit scent, strawberry scent, and the like. In an embodiment, solution 108 may include one scent. As a non-limiting example, apparatus may include jasmine scent. In another embodiments, solution 108 may include a plurality of scents. As a non-limiting example, solution 108 may include strawberry scent and mango scent. In some embodiments, a user may create one's own scent. As a non-limiting example, the user may create a new scent my mixing the jasmine scent and the pine scent.

In an embodiment, and without limitation, solution 108 may include a color element. As used in this disclosure a “color element” is a chemical and/or substance that modifies and/or alters a color of a follicle. For example, and without limitation, color element may include ammonia, wherein ammonia may open a cuticle layer of facial follicle. As a further non-limiting example, color element may comprise an oxidizing agent at varying concentrations to enter the opened cuticle layer of facial follicle such that the oxidizing agent may react with facial follicle to alter and/or modify facial follicle. In another embodiment, and without limitation, color element may include an alkaline agent such as, but not limited to ethanolamine, sodium carbonate, and the like thereof to remove a natural pigment of facial follicle. In another embodiment, and without limitation, color element may include hydrogen peroxide to modify and/or alter a hair color of facial follicle as a function of interacting with facial follicle. In another embodiment, and without limitation, color element may comprise one or more coloring products and/or pigmented dyes such as, but not limited to henna, indigo, blackcurrant, anthocynanin, and the like thereof. In another embodiment, and without limitation, color element may include one or more analytes and/or substances such as, but not limited to 1,4-diaminobenzene, 2,5-diaminotoluene, coupling agents such as, but not limited to, 1,3-diaminobenzene, 3-aminophenol, 5-amino-2-methylphenol, 1-naphthol, 2,5-diaminotoluene, 3-aminophenol, 4-chlororesorcinol, benzodioxoles, and the like thereof, and/or oxidants, such as, but not limited to, hydrogen peroxide, and the like thereof.

In an embodiment, and without limitation, solution 108 may comprise a texture element. As used in this disclosure a “texture element” is a substance and/or analyte that modifies and/or alters a texture of a hair. In an embodiment, and without limitation, solution 108 may be comprised of a texture element that converts one or more textures of hair from a first texture to a second texture. For example, and without limitation, texture element may modify a fine texture, wherein a “fine texture,” as used herein is a texture that is fragile as a function of a hair that is comprised of a cortex layer and a cuticle layer, to a medium texture, wherein a “medium texture,” as used herein is a texture that is malleable as a function of a hair that is comprised of a cortex layer, a cuticle layer, and a thin medulla layer. As a further non-limiting example, texture element may modify a medium texture to a thick texture, wherein a “thick texture,” as used herein is a texture that is thick and/or coarse as a function of a hair that is comprised of a cortex layer, a cuticle layer, and a thick medulla layer. In an embodiment, and without limitation, thick texture may include a texture that produces an impression of a thicker facial hair style. As a further non-limiting example, thick texture may be more tolerant to heat, styling products, hair dye, breakage, and the like thereof. Additionally or alternatively, solution 108 may include an acid such as, but not limited to, L-ascorbic acid. In an embodiment, and without limitation, solution 108 may comprise an amino acid such as, but not limited to L-Carnitine.

Still referring to FIG. 1, solution 108 may include an additive. As used in this disclosure an “additive” is a substance and/or product that improves and/or preserves the effect of vasodilator. In an embodiment, and without limitation, additive may comprise a terpene. As used in this disclosure a “terpene” is an unsaturated hydrocarbon consisting of the chemical composition (C5H8) n. For example, and without limitation, terpene may comprise one or more monoterpenes, sesquiterpenes, diterpenes, and the like thereof. As a further non-limiting example, terpene may include, without limitation, menthol, eucalyptol, limonene, terpenoids, eicosenoic acid, eruic acid, oleic acid, palmitic acid, monoterpenoids, peppermint oil, etc. In an embodiment, and without limitation, terpene may increase a disease resistance. In another embodiment, and without limitation, terpene may increase cell growth. In another embodiment, and without limitation, terpene may produce an aromatherapeutic effect. In another embodiment, and without limitation terpene may enhance an absorption of one or more components of solution 108.

In an embodiment, and still referring to FIG. 1, additive may include a stabilizer. As used in this disclosure a “stabilizer” is a substance and/or analyte that prevents degradation of solution 108. For example, and without limitation, stabilizer may include tris(2,4-di-tert-butylphenyl) phosphite. As a further non-limiting example, stabilizer may include Salpn. As a further non-limiting example, stabilizer may include benzophenone and/or benzotriazole. As a further non-limiting example, stabilizer may include polysorbate 60. As a further non-limiting example, stabilizer may include stearyl alcohol, cetyl alcohol, citric acid, dehydrated alcohol, lactic acid, and the like thereof. As a further non-limiting example, stabilizer may include glycol. As a further non-limiting example, stabilizer may include glycerin. As a further non-limiting example, stabilizer may include oxygen scavengers. As a further non-limiting example, stabilizer may include radical scavengers. As a further non-limiting example, stabilizer may include antiozonants. As a further non-limiting example, stabilizer may include sequestrants. As a further non-limiting example, stabilizer may include ultraviolet stabilizers. In an embodiment, and without limitation, additive may comprise an emulsifier. As used in this disclosure an “emulsifier” is a substance and/or analyte that stabilizes an emulsion. In an embodiment, and without limitation, emulsifier may stabilize an emulsion as a function of increasing a kinetic stability. In another embodiment, and without limitation, emulsifier comprise one or more amphiphilic surfactants. As used in this disclosure an “amphiphilic surfactant” is a compound that has a polar hydrophilic portion and a non-polar hydrophobic portion. In an embodiment, and without limitation, amphiphilic surfactants may produce one or more oil-in-water emulsions and/or water-in-oil emulsions. In an embodiment, and without limitation, emulsifier may comprise lecithin, soy lecithin, mucilage, sodium phosphate, monoglyceride, diglyceride, sodium stearoyl lactylate, diacetyl tartaric acid ester monoglyceride, diacetyl tartaric acid ester diglyceride, cellulose, sodium caseinate, and the like thereof. In another embodiment, and without limitation, emulsifier may comprise polysorbate 20, ceteareth 20, detergents, and the like thereof.

In an embodiment, and still referring to FIG. 1, additive may comprise a propellant. As used in this disclosure a “propellant” is a substance and/or chemical that produces a movement of a fluid and/or substance. For example, and without limitation, propellant may comprise one or more substances and/or analytes that aid in moving composition from a first location to a second location. In an embodiment, and without limitation propellant may comprise an aerosol that escapes a first location to expel solution 108 and/or move solution 108 from the first location to a second location. In an embodiment, and without limitation, propellant may include one or more analytes and/or substances such as nitrous oxide, dimethyl ether, alkanes, butane, butylated hydroxytoluene, cetyl alcohol, isobutane, propane, methane, and the like thereof. Additionally or alternatively, additive may include a moisturizer. As used in this disclosure a “moisturizer” is a substance and/or analyte that regulates water content of a tissue and/or cell. In an embodiment, and without limitation moisturizer may modify one or more rates of water loss and/or transepidermal water loss. In another embodiment, and without limitation, moisturizer may protect a tissue and/or cell as a function of preventing excessive water loss that may lead to brittle and/or rigid tissues and/or cells. In an embodiment, and without limitation, moisturizer may include an occlusive. As used in this disclosure an “occlusive” is a substance and/or chemical that prevents water and/or moisture from escaping. In an embodiment and without limitation, occlusive may include a petrolatum such as, but not limited to hydrocarbons, petroleum jellies, soft paraffins, multi-hydrocarbons, and the like thereof. In another embodiment and without limitation, occlusive may include one or more oils such as, but not limited to jojoba oil, coconut oil, and the like thereof. For example, and without limitation, jojoba oil may comprise one or more fatty acids such as, but not limited to, palmitic acid, palmitoleic acid, stearic acid, oleic acid, arachidic acid, 11-eicosenoic acid, behenic acid, erucic acid, lignoceric acid, nervonic acid, and the like thereof. As a further non-limiting example, coconut oil may comprise one or more fatty acids such as, but not limited to, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, oleic acid, and the like thereof.

In an embodiment, and still referring to FIG. 1, moisturizer may comprise a humectant. As used in this disclosure a “humectant” is a substance and/or analyte that absorbs water. In an embodiment and without limitation, humectant may draw water from a first tissue and/or cell to a second tissue and/or cell. For example, and without limitation, humectant may draw water from the dermis portion of skin to the epidermis potion of skin. As a further non-limiting example, humectant may draw water from the air to the epidermis of the skin. Additionally or alternatively, moisturizer may comprise a temporary hydration agent, such as but not limited to water, aqueous solutions, saline, deionized water, distilled water, and the like thereof. In an embodiment, and without limitation, moisturizer may comprise one or more substances and/or analytes such as cetyl alcohol, cetearyl alcohol, cocoa butter, isopropyl myristate, isopropyl palmitate, lanolin, liquid paraffin, polyethylene glycol, shea butter, silicone oil, stearic acid, stearyl alcohol, castor oil, and the like thereof. In another embodiment, and without limitation, moisturizer may comprise an antioxidant, ceramide, emulsifier, fragrance, penetration enhancer, preservative, solvent, and the like thereof. In another embodiment, and without limitation, moisturizer may comprise a lotion, cream, ointment, bath oil, soap, soap substitute, and the like thereof.

With continued reference to FIG. 1, in some embodiments, apparatus 100 may include a housing 116. For the purposes of this disclosure, a “housing” is a structure configured to contain a plurality of components, such as, without limitation, components of apparatus 100 as described in this disclosure. In some embodiments, housing 116 may be designed and configured to protect sensitive components of apparatus 100 from damage or contamination. In a non-limiting example, housing 116 may be configured to encase, protect or contain solution applying module 104, reservoir 112, or the like. In some embodiments, housing 116 may be disposable. In some embodiments, housing 116 may be reusable. In some embodiments, housing 116 may be portable. In some cases, housing 116 may include a durable, lightweight material such as without limitation, plastic, metal, polyester, paper membrane and/or the like. In some embodiments, housing 116 may include a tab, wherein the tab is configured to assist taking housing 116 out. In some embodiments, housing 116 may include glass, steel, aluminum, plastic, polyethylene terephthalate (PET), polypropylene (PP), high density polyethelene (HDPE), polylactic acid (PLA), wood fiber, bamboo, palm leaf, or the like.

With continued reference to FIG. 1, apparatus 100 includes a reservoir 112, wherein the reservoir is configured to store solution 108. As used in this disclosure, a “reservoir” is a place where a substance or solution is held. Reservoir 112 may include plastics, stainless steel, glass, rubber, silicone, ceramics, or the like. In an embodiment, apparatus 100 may include one reservoir 112. Reservoir 112 may include various shapes. In another embodiment, apparatus 100 may include a plurality of reservoirs 112. In some embodiments, each of plurality of reservoirs 112 may include different solution 108. In some embodiments, apparatus 100 may include a plurality of solution applying module 104; for instance, one solution applying module 104 for each of plurality of reservoirs 112. In an embodiment, a plurality of reservoirs 112 may include same size. In some embodiments, a plurality of reservoirs 112 may include different sizes. In some embodiments, user may hold apparatus 100 by holding reservoir 112. In some embodiments, user may hold apparatus 100 by holding a handle. In a non-limiting example, reservoir 112 may be inside of handle.

With continued reference to FIG. 1, in some embodiments, reservoir 112 may be located on the bottom of solution applying module 104. In some embodiments, With continued reference to the solution applying module 104 may be interchangeable, allowing different applicators to be attached for varying application techniques. As used in this disclosure, “interchangeable” is the capability of a component or module to be replaced, substituted, or exchanged with another component or module of similar or compatible design, without requiring permanent modification to the system. Without limitation, this may include but is not limited to components such as applicators, attachments, or interfaces, which may be swapped to accommodate varying functionalities, application techniques, or user preferences. For instance, the reservoir 112 may be interchangeable, the solution 108 may be interchangeable, the solution applying module 104 may be interchangeable, the solution flow generating module 120 may be interchangeable, and/or the housing 116 may be interchangeable. In some embodiments, reservoir 112 may be removable connected to solution applying module 104. For the purposes of this disclosure, “removably connected” refers to an ability for an object that is connected to another object to be disconnected from the other object without damaging or breaking said objects. In some embodiments, the removable connection may include threaded connection. For the purposes of this disclosure, “threaded connection” is a type of connection that involves mating male and female halves together to create a connection to hold the threads together. As a non-limiting example, the threaded connection may be done by way of gendered mating components. As a non-limiting example, the gendered mating components may include a male component or plug which is inserted within a female component or socket. In some cases, the threaded connection may be removable. In some cases, the threaded connection may be removable, but requires a specialized tool or key for removal. In some embodiments, the threaded connection may be achieved by way of one or more of plug and socket mates, pogo pin contact, crown spring mates, and the like. In some cases, the threaded connection may be keyed to ensure proper alignment of a mating component. In some cases, the threaded connection may be lockable. As used in this disclosure, a “mating component” is a component that mates with at least another component. As a non-limiting example, the mating component may include a connector. In another embodiment, the removable connection may include bayonet connections. The bayonet connections uses a locking mechanism that allows the two components to be connected by inserting and twisting them into place. In another embodiment, the removable connection may include snap-fit connections. In some embodiments, the snap-fit connections may include a series of tabs or hooks that snap into place when the two components are pushed together. As a non-limiting example, the snap-fit connections may include snap-fit clips, snap-fit tabs, snap-fit hinges, snap-fit latches, snap-fit hooks, snap-fit pins, and the like. In another embodiment, the removable connection may include latch connections. The latch connections uses a latch or locking mechanism that secures the two components together. As a non-limiting example, the latch connections may include cabinet latches, door latches, aircraft fasteners, and the like. In another embodiment, the removable connection may include clamp connections. In some embodiments, the clamp connections uses a clamp or compression mechanism to hold the two components together. As a non-limiting example, the clamp connections may include hose clamps, c-clamps, pipe clamps, wire rope clamps, shaft collars, spring clamps, and the like. In another embodiment, the removable connection may include magnetic connections. In some embodiments, the magnetic connections uses magnets to hold the two components together. In some embodiments, the removable connection may include connectors, screws, adapters, feedthrough, and the like. For the purposes of this disclosure, a “connector” is a component configured to create an electrical or mechanical connection between two or more objects. Examples of connectors include plug and socket connectors, terminal blocks, crimp connectors, and the like.

With continued reference to FIG. 1, in some embodiments, reservoir 112 may include an indicator. Without limitation, the 112 reservoir may include the indicator configured to display a remaining quantity of the solution. As used in this disclosure, an “indicator” is a mark that indicates the amount of a substance that can be filled in a container. In some embodiments, indicator may be configured to indicate a preferred fill level or solution usage level of solution 108. As used in this disclosure, a “preferred fill level for a substance” refers to a level of a substance to be filled in a reservoir that is set as a suggestion. As a non-limiting example, the indicator may mark a preferred fill level for solution 108 in the middle of inside of reservoir 112. As used in this disclosure, a “remaining solution” is the quantity of a liquid or substance contained within a reservoir that has not yet been dispensed or utilized. Without limitation, the remaining solution may include but is not limited to the measurable volume, weight, or percentage of the solution present, as indicated by a display or indicator configured to provide real-time feedback to the user. In an embodiment, the indicator may include various features that provide information about the solution level within the reservoir. For instance, without limitation, the indicator may include visual markings, such as graduated lines, symbols, or color-coded sections, which may be directly marked on the exterior or interior of the reservoir. Continuing, these markings may represent distinct volume levels, enabling a user to assess the amount of solution remaining at a glance. Additionally and or alternatively, the indicator may include color-changing capabilities, such as chemically responsive materials or LED-illuminated displays, that may alter their appearance to signify different fill levels. For example, without limitation, the indicator may display distinct colors to denote whether the reservoir is full, half-full, or nearly empty, enhancing ease of use. In another non-limiting example, the indicator may further incorporate integrated displays, such as LCD or LED screens, which may be embedded into the reservoir or connected via a system interface. Without limitation, these displays may present real-time numerical or graphical representations of the solution level, offering precise feedback to the user. In another non-limiting example, the indicator may include auditory alerts, such as devices configured to emit a sound or signal when the solution reaches specific levels, such as the minimum or maximum capacity. Continuing, this feature may provide an additional layer of functionality, particularly in scenarios where visual indicators may not be immediately accessible or effective.

In some embodiments, indicator may include a plurality of indicators. In some embodiments, indicator may be configured to indicate a maximum fill level of solution 108. As used in this disclosure, a “maximum fill level for a substance” refers to a maximum level that is set as an upper limitation that a substance is designed to be filled. In an embodiment, indicator may be a point mark. As a non-limiting example, the point mark may include a circle mark, a triangle mark, a square mark, an arrow mark, and the like. In another embodiment, indicator may be a line mark. As a non-limiting example, the line mark may be a full line along the circumference of reservoir 112. In an embodiment, indicator may be caved in. In another embodiment, indicator may be a protruded. In some embodiments, indicator may be drawn. In some embodiments, indicator may be a sticker. As used in this disclosure, a “sticker” is an adhesive label. In some embodiments, indicator may be located inside of reservoir 112. In some embodiments, indicator may include a plurality of indicators. As a non-limiting example, reservoir 112 may include a first indicator on a first side and a second indicator on a second side.

With continued reference to FIG. 1, apparatus 100 includes a solution flow generating module 120, wherein the solution flow generating module 120 is configured to generate a flow between reservoir 112 and solution applying module 104. Solution flow generating module 120 may include plastics, stainless steel, glass, rubber, silicone, ceramics, or the like. In some embodiments, solution flow generating module 120 may be manipulated by a user. As a non-limiting example, user may manually control actuators to generate flow between reservoir 112 and solution applying module 104 to apply solution 108 on skin. In some embodiments, solution flow generating module 120 may be controlled using a computing device. In an embodiment, the solution flow generating module 120 may be controlled by a computing device configured to automate dispensing of the solution 108. The computing device disclosed herein is further described with respect to FIG. 6.

With continued reference to FIG. 1, in some embodiments, solution flow generating module 120 may include flow port. In some embodiments, flow port may be fluidically connected to reservoir 112 and solution applying module 104. As used in this disclosure, “flow port” is a port that allows a flow of a substance. In some embodiments, flow port may include a tube-like structure that may allow a bidirectional flow of a substance to and from reservoir. As a non-limiting example, flow port may include a plastic tube that may enter housing 116 or solution applying module 104. In some embodiments, a user may deliver one or more solution 108 to reservoir 112 through flow port.

With continued reference to FIG. 1, in some embodiments, solution flow generating module 120 may include a pump. For the purposes of this disclosure, a “pump” is any element of a mechanical component that converts mechanical power into fluidic energy. Pump may include a substantially constant pressure pump (e.g., centrifugal pump) or a substantially constant flow pump (e.g., positive displacement pump, gear pump, and the like). Pump can be hydrostatic or hydrodynamic. In some embodiments, pump may be actuated manually or by using an actuator. A pump may generate flow with enough power to overcome pressure induced by a load at a pump outlet. A pump may generate a vacuum at a pump inlet, thereby forcing fluid from a reservoir 112 into the pump inlet to the pump and by mechanical action delivering this fluid to a pump outlet. Hydrostatic pumps are positive displacement pumps. Hydrodynamic pumps can be fixed displacement pumps, in which displacement may not be adjusted, or variable displacement pumps, in which the displacement may be adjusted. Exemplary non-limiting pumps include gear pumps, rotary vane pumps, screw pumps, bent axis pumps, inline axial piston pumps, radial piston pumps, and the like. Pump may be powered by any rotational mechanical work source, for example without limitation and electric motor or a power take off from an engine. Pump may be in fluidic communication with at least a reservoir 112. In some cases, reservoir 112 may be unpressurized and/or vented. Alternatively, reservoir 112 may be pressurized and/or sealed.

With continued reference to FIG. 1, in an embodiment, a pump may include a gas transfer pump. For the purposes of this disclosure, a “gas transfer pump” is a type of pump that works by mechanically moving a solution. As a non-limiting example, the gas transfer pump may include a positive displacement vacuum pump. For the purposes of this disclosure, a “positive displacement vacuum pump” is a pump that contains chambers that alternately expand and contract with a check or a one-way valve to draw and eject flow. As a non-limiting example, the positive displacement vacuum pump may include reciprocating vacuum pump, reciprocating piston vacuum pump, plunger vacuum pump, diaphragm vacuum pump, rotary vacuum pump, rotary vane vacuum pump, liquid ring vacuum pump, rotary piston vacuum pump, screw vacuum pump, gear vacuum pump, lobe vacuum pump, scroll vacuum pump, and the like. As another non-limiting example, the gas transfer pump may include momentum transfer pump. For the purposes of this disclosure, a “momentum transfer pump” is a type of pump that works by inducing the movement of a solution through kinetic energy transfer. As a non-limiting example, the momentum transfer pump may include turbomolecular vacuum pump, diffusion vacuum pump, and the like.

With continued reference to FIG. 1, in some embodiments, controlling the solution flow generating module 120 may include using an actuator to regulate an amount of solution 108 dispensed. As used in this disclosure, an “amount” is a measurable quantity of a substance that may be dispensed, controlled, or regulated. For the purposes of this disclosure, an “actuator” is a component of a machine that is responsible for moving and/or controlling a mechanism or system. The actuator may, in some cases, require a control signal and/or a source of energy or power. In some cases, a control signal may be relatively low energy. Exemplary control signal forms include electric potential or current, pneumatic pressure or flow, or hydraulic fluid pressure or flow, mechanical force/torque or velocity, or even human power. In some cases, the actuator may have an energy or power source other than control signal. This may include a main energy source, which may include for example electric power, hydraulic power, pneumatic power, mechanical power, and the like. In some cases, upon receiving a control signal, the actuator may respond by converting source power into mechanical motion. In some cases, the actuator may be understood as a form of automation or automatic control.

With continued reference to FIG. 1, in some embodiments, an actuator may include a hydraulic actuator. The hydraulic actuator may consist of a cylinder or fluid motor that uses hydraulic power to facilitate mechanical operation. Output of the hydraulic actuator may include mechanical motion, such as without limitation linear, rotatory, or oscillatory motion. In some cases, the hydraulic actuator may employ a liquid hydraulic fluid. As liquids, in some cases. are incompressible, a hydraulic actuator can exert large forces. Additionally, as force is equal to pressure multiplied by area, the hydraulic actuators may act as force transformers with changes in area (e.g., cross sectional area of cylinder and/or piston). An exemplary hydraulic cylinder may consist of a hollow cylindrical tube within which a piston can slide. In some cases, the hydraulic cylinder may be considered single acting. The single acting may be used when fluid pressure is applied substantially to just one side of a piston. Consequently, a single acting piston can move in only one direction. In some cases, a spring may be used to give a single acting piston a return stroke. In some cases, a hydraulic cylinder may be double acting. The double acting may be used when pressure is applied substantially on each side of a piston; any difference in resultant force between the two sides of the piston causes the piston to move.

With continued reference to FIG. 1, in some embodiments, an actuator may include a pneumatic actuator. In some cases, the pneumatic actuator may enable considerable forces to be produced from relatively small changes in gas pressure. In some cases, the pneumatic actuator may respond more quickly than other types of actuators, for example hydraulic actuators. The pneumatic actuator may use compressible fluid (e.g., air). In some cases, the pneumatic actuator may operate on compressed air. Operation of hydraulic and/or pneumatic actuators may include control of one or more valves, circuits, fluid pumps, and/or fluid manifolds.

With continued reference to FIG. 1, an actuator may be an electric actuator. In some embodiments, the electric actuator may include any electromechanical actuators, linear motors, and the like. In some cases, the actuator may include an electromechanical actuator. The electromechanical actuator may convert a rotational force of an electric rotary motor into a linear movement to generate a linear movement through a mechanism. Exemplary mechanisms, include rotational to translational motion transformers, such as without limitation a belt, a screw, a crank, a cam, a linkage, a scotch yoke, and the like. In some cases, control of an electromechanical actuator may include control of electric motor, for instance a control signal may control one or more electric motor parameters to control electromechanical actuator. Exemplary non-limitation electric motor parameters include rotational position, input torque, velocity, current, and potential. The electric actuator may include a linear motor. The linear motors may differ from electromechanical actuators, as power from linear motors is output directly as translational motion, rather than output as rotational motion and converted to translational motion. In some cases, the linear motor may cause lower friction losses than other devices. The linear motors may be further specified into at least 3 different categories, including flat linear motor, U-channel linear motors and tubular linear motors. The linear motors may be directly controlled by a control signal for controlling one or more linear motor parameters. Exemplary linear motor parameters include without limitation position, force, velocity, potential, and current.

With continued reference to FIG. 1, in some embodiments, an actuator may include a mechanical actuator. In some cases, the mechanical actuator may function to execute movement by converting one kind of motion, such as rotary motion, into another kind, such as linear motion. An exemplary mechanical actuator may include a rack and pinion. In some cases, a mechanical power source, such as a power take off may serve as power source for the mechanical actuator. The mechanical actuators may employ any number of mechanisms, including for example without limitation gears, rails, pulleys, cables, linkages, and the like.

With continued reference to FIG. 1, apparatus 100 may include a computing device. Computing device may include any computing device as described in this disclosure, including without limitation a microcontroller, microprocessor, digital signal processor (DSP) and/or system on a chip (SoC) as described in this disclosure. Computing device may include, be included in, and/or communicate with a mobile device such as a mobile telephone or smartphone. Computing device may include a single computing device operating independently, or may include two or more computing device operating in concert, in parallel, sequentially or the like; two or more computing devices may be included together in a single computing device or in two or more computing devices. Computing device may interface or communicate with one or more additional devices as described below in further detail using a network interface device. Network interface device may be utilized for connecting Computing device to one or more of a variety of networks, and one or more devices. Examples of a network interface device include, but are not limited to, a network interface card (e.g., a mobile network interface card, a LAN card), a modem, and any combination thereof. Examples of a network include, but are not limited to, a wide area network (e.g., the Internet, an enterprise network), a local area network (e.g., a network associated with an office, a building, a campus or other relatively small geographic space), a telephone network, a data network associated with a telephone/voice provider (e.g., a mobile communications provider data and/or voice network), a direct connection between two computing devices, and any combinations thereof. A network may employ a wired and/or a wireless mode of communication. In general, any network topology may be used. Information (e.g., data, software etc.) may be communicated to and/or from a computer and/or a computing device. Computing device may include but is not limited to, for example, a computing device or cluster of computing devices in a first location and a second computing device or cluster of computing devices in a second location. Computing device may include one or more computing devices dedicated to data storage, security, distribution of traffic for load balancing, and the like. Computing device may distribute one or more computing tasks as described below across a plurality of computing devices of computing device, which may operate in parallel, in series, redundantly, or in any other manner used for distribution of tasks or memory between computing devices. Computing device may be implemented using a “shared nothing” architecture in which data is cached at the worker, in an embodiment, this may enable scalability of apparatus 100 and/or computing device.

With continued reference to FIG. 1, computing device may be designed and/or configured to perform any method, method step, or sequence of method steps in any embodiment described in this disclosure, in any order and with any degree of repetition. For instance, computing device may be configured to perform a single step or sequence repeatedly until a desired or commanded outcome is achieved; repetition of a step or a sequence of steps may be performed iteratively and/or recursively using outputs of previous repetitions as inputs to subsequent repetitions, aggregating inputs and/or outputs of repetitions to produce an aggregate result, reduction or decrement of one or more variables such as global variables, and/or division of a larger processing task into a set of iteratively addressed smaller processing tasks. Computing device may perform any step or sequence of steps as described in this disclosure in parallel, such as simultaneously and/or substantially simultaneously performing a step two or more times using two or more parallel threads, processor cores, or the like; division of tasks between parallel threads and/or processes may be performed according to any protocol suitable for division of tasks between iterations. Persons skilled in the art, upon reviewing the entirety of this disclosure, will be aware of various ways in which steps, sequences of steps, processing tasks, and/or data may be subdivided, shared, or otherwise dealt with using iteration, recursion, and/or parallel processing.

With continued reference to FIG. 1, the solution applying module 104 may include an applicator configured to apply the solution to one or more of under, above, through, or on top of hair shafts. As used in this disclosure, an “applicator” is a device, structure, or mechanism configured to facilitate the delivery, distribution, or application of a solution to a target surface, material, or area. Without limitation, the applicator may include any type of applicator described within this specification, including but not limited to brushes, pads, tine structures, nozzles, rollers, and combinations thereof. The applicator may be configured for use in various orientations or methods of application, depending on the intended use, and may incorporate additional features to enhance functionality, such as metering, dispensing, or solution retention capabilities. Without limitation, this configuration may allow for versatile application techniques, ensuring that the solution can effectively interact with the hair in various orientations or positions, depending on the desired use case or treatment method. Continuing, the applicator's design may accommodate multiple application paths to enhance coverage and efficacy. In a non-limiting example, the applicator may include a tine structure with bristles or nodes designed to distribute the solution along the hair shaft. Without limitation, the applicator may also comprise a pad for smooth application across hair strands or a nozzle configured to deliver the solution precisely into the hair roots or follicles. Additionally, the applicator may include a roller mechanism for evenly spreading the solution or a comb-like structure to part hair while simultaneously dispensing the solution to specific areas.

Referring now to FIG. 2, an exemplary embodiment of apparatus 100 for applying solution on skin is illustrated. Apparatus 100 includes reservoir 112, solution applying module 104, solution flow generating module 120, housing 116, and the like. This may be implemented with respect to FIG. 1. In some embodiments, solution applying module 104 and solution flow generating module 120 may allow to provide metered dose of solution 108. In some embodiments, solution applying module 104 may be rubbed into skin to apply solution 108 on skin. In some embodiments, flow generating module 120 may include an actuator 200. As a non-limiting example, actuator 200 may include a button, lever, switch, or the like. In some embodiments, actuator 200 may be manually manipulated by a user or automatically actuated using a controller or computing device. Actuator 200 disclosed herein is further described with respect to FIG. 1.

Referring now to FIGS. 3A-I, exemplary illustrations 300a-i of apparatus 100 for applying solution on skin are shown. Exemplary configurations of solution applying module 104 and reservoir 112 are shown. As shown in FIG. 3A, solution applying module 104 and reservoir 112 may be removable connected. In some embodiments, solution applying module 104 may include toothed or comb-like shape. In some embodiments, reservoir 112 may include tube. In some embodiments, reservoir 112 may include housing 116 that is removable and disposable or reusable. In some embodiments, as shown in FIG. 3B, reservoir 112 may be squeezed or pushed to generate flow of solution 108 to solution applying module 104. In some embodiments, solution applying module 104 may include felt or chisel tip made of a porous material that allows solution 108 to flow through. In some embodiments, solution flow generating module 120 may include capillary action that allows solution 108 to be drawn from reservoir 112 to solution applying module 104. As shown in FIG. 3C, solution applying module 104 may include pad-based applicator and solution flow generating module 120 may include flow port. In some embodiments, solution flow generating module 120 may include a screw-plunger mechanism. For the purposes of this disclosure, a “screw” is a threaded rod or cylinder with a spiral groove wrapped around it. As a user rotate a screw, in a non-limiting example, the screw may move either upward or downward along its axis, depending on the direction of rotation. This rotational motion may translate into linear motion, making it a versatile force amplifier. For the purposes of this disclosure, a “plunger” is a cylindrical or rod-shaped device that fits within a cavity or tube. The plunger may move in a linear fashion, and it may be used to create pressure or displace a substance or solution within a confined space such as but not limited to reservoir 112. In a non-limiting example, screw threads may engage with corresponding threads inside the plunger or its housing. As a user rotate the screw, it may either push the plunger down or pull it up, depending on the arrangement. The plunger, when pushed, may dispense the precise dosage of solution 108. In some embodiments, as shown in FIG. 3D, solution applying module 104 may include a tine structure. As used in this disclosure, a “tine structure” is a configuration comprising one or more elongated, projecting elements, which may be arranged individually or in a series. Continuing, the projections may resemble teeth, prongs, or similar features and may vary in size, spacing, orientation, and function. Without limitation, the tine structure may include structures such as the teeth of a comb, isolated tooth-like elements, and/or other analogous formations designed for interaction with a surface, material, or environment. Without limitation, the tine structure may include teeth, prongs, bristles 304, or nodes, which may be arranged individually or in a series and may vary in size, spacing, orientation, and function to optimize the application process. Without limitation, the tine structure may include bristles 304, wherein the bristles 304 distribute, using one or more prongs, the solution 108 on the skin. In an embodiment, the tine structure may comprise a comb-like or tooth-like arrangement, enabling uniform distribution of the solution 108 across a surface. Additionally and or alternatively, the tine structure may include bristles 304 formed from materials such as synthetic or natural plant fibers to provide a soft yet effective application mechanism. In another embodiment, the tine structure may be comprised of rubber, plastic, and/or silicone, offering durability and flexibility for use across various surface types. Without limitation, these configurations may provide versatility in the application method, allowing for targeted or broad application depending on the specific design and material properties of the tine structure. In an embodiment, the tine structure may include bristles 304 or nodes. In some embodiments, solution applying module 104 may include holes. In a non-limiting example, nodes 308 of solution applying module 104 may include holes, allowing solution 108 to flow through the holes. In an embodiment, bristles may include micro-bristles which may facilitate the precise application of a drug product under hair by effectively reaching the skin surface. Continuing, the micro-bristles may part hair strands and ensure uniform distribution of the product, promoting optimal absorption into the skin. Without limitation, this feature may enhance the effectiveness of topical treatments, particularly in areas where hair coverage might otherwise hinder direct contact with the skin.

With continued reference to FIG. 3A-I, in some embodiments, as shown in FIG. 3E-G, apparatus 100 may incorporate a razor-like intuitive and ergonomic design that facilitates seamless integration into a user's normal routine. Continuing, the familiar form factor may allow users to comfortably handle and operate the device with minimal effort or learning curve. Without limitation, the ergonomic design may promote ease of use, particularly for men who are accustomed to similar grooming tools, enabling the solution to be adopted effortlessly. Continuing, the apparatus 100 ergonomic design may encourage consistent and effective application of the drug product. In a non-limiting example, such an approach may enhance user compliance and satisfaction, ultimately supporting improved treatment outcomes.

With continued reference to FIG. 3A-I, in some embodiments, as shown in FIG. 3G, apparatus 100 may incorporate a metering mechanism designed to ensure precise and consistent dosing of the solution 108. Without limitation, the metering mechanism may incorporate a sliding plunger with predetermined stoppage points, allowing for controlled and accurate delivery of the solution 108. Continuing, this feature may enhance user confidence by providing reliable, repeatable application without the need for manual measurement. In some embodiments, the metering mechanism may include prefilled applicator heads, which may simplify the process and reduce the potential for dosing errors. Continuing, this design may improve convenience, minimize waste, and promote consistent treatment outcomes for the user. In an embodiment, the metering mechanism may be configured to regulate an amount of the solution dispensed during application.

With continued reference to FIG. 3A-I, in some embodiments, as shown in FIG. 3H, apparatus 100 may include a lever mechanism, wherein the lever mechanism is configured to move the solution 108 to the solution applying module 104. As used in this disclosure, a “lever mechanism” is a mechanical structure configured to transmit force through a pivot or fulcrum to achieve movement or actuation of a connected component. Without limitation, the lever mechanism may be configured to facilitate the movement of the solution 108 to the solution applying module 104, allowing for controlled dispensing or application. Continuing, the lever mechanism may include, without limitation, an actuator 320, as defined herein, such as a handle, arm, or similar structure that operates through manual or automated activation to create the necessary force or pressure to transport the solution 108.

With continued reference to FIG. 3A-I, in some embodiments, as shown in FIG. 3I, apparatus 100 may include a wheel mechanism 324, wherein the wheel mechanism 324 is configured to force the solution 108 out of a reservoir 112 when twisted. As used in this disclosure, a “wheel mechanism” is a rotatable structure configured to convert rotational motion into force or pressure to move a solution from a containment area to an outlet or applying module. Without limitation, the wheel mechanism 324 may be configured to facilitate controlled dispensing of the solution 108 by twisting or rotating the wheel, which may generate sufficient pressure within the reservoir 112 to move the solution 108 outward to the solution applying module 104. Continuing, the wheel mechanism 324 may include, without limitation, a rotatable actuator, such as a knob, dial, or similar structure, that operates manually or automatically to dispense the solution 108.

With continued reference to FIG. 1, in some embodiments, apparatus 100 may allow precision application of solution 108; for instance, to avoid inadvertent drug exposure to eyes, nose, mouth, or the like. In some embodiments, apparatus 100 may allow increased user convenience; for instance, for hands-free delivery of solution 108 to avoid cleanup, increase ease-of-use, or the like. In some embodiments, apparatus 100 may facilitate rubbing drug product (solution 108) to sin between fair follicle. In some embodiments, apparatus 100 may allow for metered dosing; for instance, dispensing appropriate and targeted dose of solution 108.

With continued reference to FIG. 1, in some embodiments, apparatus 100 may prevent clogging in solution applying module 104 during dispensing solution 108, dispense a dose of solution 108 to within accuracy, consumer friendly (i.e. hands-free), commercial requirements supporting subscription model, e-commerce, facilitate the distribution and application of product to face, or the like. In some embodiments, apparatus 100 may include difference solution applying module 104 for supporting eyebrow and facial hair surface area.

Referring now to FIG. 4, a flow diagram of an exemplary method 400 of applying solution on skin is illustrated. Method 400 includes a step 405 of storing, using a reservoir, a solution. This may be implemented as disclosed with respect to FIGS. 1-3.

With continued reference to FIG. 4, method 400 includes a step 410 of generating, using a solution flow generating module, a flow of the solution between a reservoir and a solution applying module. This may be implemented as disclosed with respect to FIGS. 1-3.

With continued reference to FIG. 4, method 400 includes a step 415 of applying, using a solution applying module, a solution on skin. This may be implemented as disclosed with respect to FIGS. 1-3.

It is to be noted that any one or more of the aspects and embodiments described herein may be conveniently implemented using one or more machines (e.g., one or more computing devices that are utilized as a user computing device for an electronic document, one or more server devices, such as a document server, etc.) programmed according to the teachings of the present specification, as will be apparent to those of ordinary skill in the computer art. Appropriate software coding can readily be prepared by skilled programmers based on the teachings of the present disclosure, as will be apparent to those of ordinary skill in the software art. Aspects and implementations discussed above employing software and/or software modules may also include appropriate hardware for assisting in the implementation of the machine executable instructions of the software and/or software module.

Such software may be a computer program product that employs a machine-readable storage medium. A machine-readable storage medium may be any medium that is capable of storing and/or encoding a sequence of instructions for execution by a machine (e.g., a computing device) and that causes the machine to perform any one of the methodologies and/or embodiments described herein. Examples of a machine-readable storage medium include, but are not limited to, a magnetic disk, an optical disc (e.g., CD, CD-R, DVD, DVD-R, etc.), a magneto-optical disk, a read-only memory “ROM” device, a random access memory “RAM” device, a magnetic card, an optical card, a solid-state memory device, an EPROM, an EEPROM, and any combinations thereof. A machine-readable medium, as used herein, is intended to include a single medium as well as a collection of physically separate media, such as, for example, a collection of compact discs or one or more hard disk drives in combination with a computer memory. As used herein, a machine-readable storage medium does not include transitory forms of signal transmission.

Such software may also include information (e.g., data) carried as a data signal on a data carrier, such as a carrier wave. For example, machine-executable information may be included as a data-carrying signal embodied in a data carrier in which the signal encodes a sequence of instruction, or portion thereof, for execution by a machine (e.g., a computing device) and any related information (e.g., data structures and data) that causes the machine to perform any one of the methodologies and/or embodiments described herein.

Examples of a computing device include, but are not limited to, an electronic book reading device, a computer workstation, a terminal computer, a server computer, a handheld device (e.g., a tablet computer, a smartphone, etc.), a web appliance, a network router, a network switch, a network bridge, any machine capable of executing a sequence of instructions that specify an action to be taken by that machine, and any combinations thereof. In one example, a computing device may include and/or be included in a kiosk.

FIG. 5 shows a diagrammatic representation of one embodiment of a computing device in the exemplary form of a computer system 500 within which a set of instructions for causing a control system to perform any one or more of the aspects and/or methodologies of the present disclosure may be executed. It is also contemplated that multiple computing devices may be utilized to implement a specially configured set of instructions for causing one or more of the devices to perform any one or more of the aspects and/or methodologies of the present disclosure. Computer system 500 includes a processor 504 and a memory 508 that communicate with each other, and with other components, using a bus 512. Bus 512 may include any of several types of bus structures including, but not limited to, a memory bus, a memory controller, a peripheral bus, a local bus, and any combinations thereof, using any of a variety of bus architectures.

Processor 504 may include any suitable processor, such as without limitation a processor incorporating logical circuitry for performing arithmetic and logical operations, such as an arithmetic and logic unit (ALU), which may be regulated with a state machine and directed by operational inputs from memory and/or sensors; processor 504 may be organized according to Von Neumann and/or Harvard architecture as a non-limiting example. Processor 504 may include, incorporate, and/or be incorporated in, without limitation, a microcontroller, microprocessor, digital signal processor (DSP), Field Programmable Gate Array (FPGA), Complex Programmable Logic Device (CPLD), Graphical Processing Unit (GPU), general purpose GPU, Tensor Processing Unit (TPU), analog or mixed signal processor, Trusted Platform Module (TPM), a floating point unit (FPU), and/or system on a chip (SoC) Memory 508 may include various components (e.g., machine-readable media) including, but not limited to, a random-access memory component, a read only component, and any combinations thereof. In one example, a basic input/output system 516 (BIOS), including basic routines that help to transfer information between elements within computer system 500, such as during start-up, may be stored in memory 508. Memory 508 may also include (e.g., stored on one or more machine-readable media) instructions (e.g., software) 520 embodying any one or more of the aspects and/or methodologies of the present disclosure. In another example, memory 508 may further include any number of program modules including, but not limited to, an operating system, one or more application programs, other program modules, program data, and any combinations thereof.

Computer system 500 may also include a storage device 524. Examples of a storage device (e.g., storage device 524) include, but are not limited to, a hard disk drive, a magnetic disk drive, an optical disc drive in combination with an optical medium, a solid-state memory device, and any combinations thereof. Storage device 524 may be connected to bus 512 by an appropriate interface (not shown). Example interfaces include, but are not limited to, SCSI, advanced technology attachment (ATA), serial ATA, universal serial bus (USB), IEEE 1394 (FIREWIRE), and any combinations thereof. In one example, storage device 524 (or one or more components thereof) may be removably interfaced with computer system 500 (e.g., using an external port connector (not shown)). Particularly, storage device 524 and an associated machine-readable medium 528 may provide nonvolatile and/or volatile storage of machine-readable instructions, data structures, program modules, and/or other data for computer system 500. In one example, software 520 may reside, completely or partially, within machine-readable medium 528. In another example, software 520 may reside, completely or partially, within processor 504.

Computer system 500 may also include an input device 532. In one example, a user of computer system 500 may enter commands and/or other information into computer system 500 using input device 532. Examples of an input device 532 include, but are not limited to, an alpha-numeric input device (e.g., a keyboard), a pointing device, a joystick, a gamepad, an audio input device (e.g., a microphone, a voice response system, etc.), a cursor control device (e.g., a mouse), a touchpad, an optical scanner, a video capture device (e.g., a still camera, a video camera), a touchscreen, and any combinations thereof. Input device 532 may be interfaced to bus 512 using any of a variety of interfaces (not shown) including, but not limited to, a serial interface, a parallel interface, a game port, a USB interface, a FIREWIRE interface, a direct interface to bus 512, and any combinations thereof. Input device 532 may include a touch screen interface that may be a part of or separate from display 536, discussed further below. Input device 532 may be utilized as a user selection device for selecting one or more graphical representations in a graphical interface as described above.

A user may also input commands and/or other information to computer system 500 using storage device 524 (e.g., a removable disk drive, a flash drive, etc.) and/or network interface device 540. A network interface device, such as network interface device 540, may be utilized for connecting computer system 500 to one or more of a variety of networks, such as network 544, and one or more remote devices 548 connected thereto. Examples of a network interface device include, but are not limited to, a network interface card (e.g., a mobile network interface card, a LAN card), a modem, and any combination thereof. Examples of a network include, but are not limited to, a wide area network (e.g., the Internet, an enterprise network), a local area network (e.g., a network associated with an office, a building, a campus or other relatively small geographic space), a telephone network, a data network associated with a telephone/voice provider (e.g., a mobile communications provider data and/or voice network), a direct connection between two computing devices, and any combinations thereof. A network, such as network 544, may employ a wired and/or a wireless mode of communication. In general, any network topology may be used. Information (e.g., data, software 520, etc.) may be communicated to and/or from computer system 500 using network interface device 540.

Computer system 500 may further include a video display adapter 552 for communicating a displayable image to a display device, such as display device 536. Examples of a display device include, but are not limited to, a liquid crystal display (LCD), a cathode ray tube (CRT), a plasma display, a light emitting diode (LED) display, and any combinations thereof. Display adapter 552 and display device 536 may be utilized in combination with processor 504 to provide graphical representations of aspects of the present disclosure. In addition to a display device, computer system 500 may include one or more other peripheral output devices including, but not limited to, an audio speaker, a printer, and any combinations thereof. Such peripheral output devices may be connected to bus 512 using a peripheral interface 556. Examples of a peripheral interface include, but are not limited to, a serial port, a USB connection, a FIREWIRE connection, a parallel connection, and any combinations thereof.

The foregoing has been a detailed description of illustrative embodiments of the invention. Various modifications and additions can be made without departing from the spirit and scope of this invention. Features of each of the various embodiments described above may be combined with features of other described embodiments as appropriate in order to provide a multiplicity of feature combinations in associated new embodiments. Furthermore, while the foregoing describes a number of separate embodiments, what has been described herein is merely illustrative of the application of the principles of the present invention. Additionally, although particular methods herein may be illustrated and/or described as being performed in a specific order, the ordering is highly variable within ordinary skill to achieve apparatuses and methods according to the present disclosure. Accordingly, this description is meant to be taken only by way of example, and not to otherwise limit the scope of this invention.

Exemplary embodiments have been disclosed above and illustrated in the accompanying drawings. It will be understood by those skilled in the art that various changes, omissions and additions may be made to that which is specifically disclosed herein without departing from the spirit and scope of the present invention.

APPARATUS AND METHOD FOR APPLYING A SOLUTION ON SKIN

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

CROSS-REFERENCE TO RELATED APPLICATIONS

Provisional Applications (1)